Effect of Crystallization Inhibitors on Vascular Calcifications Induced by Vitamin D : A Pilot Study in Sprague-Dawley Rats

概要

論文の詳細を見る
Background Pathological calcification in soft tissues (ie, ectopic calcification) can have severe consequences. Hydroxyapatite is the common mineral phase present in all tissue calcifications. In general, the development of tissue calcifications requires a pre-existing injury as an inducer (heterogeneous nucleant), whereas further progression requires the presence of other promoter factors (such as hypercalcemia and/or hyperphosphatemia) and/or a deficiency in calcification represser factors (crystallization inhibitors and cellular defense mechanisms). The present study investigated the capacity of etidronate (a bisphosphonate used in osteoporosis treatment) and phytate (a natural product) to inhibit vascular calcification in rats. Methods and Results Six male Sprague-Dawley rats in each of the 3 treatment groups were subcutaneously injected with either a placebo (physiological serum solution), etidronate (0.825μmol・kg^<-1>・day^<-1>) or phytate (0.825μmol・kg^<-1>・day^<-1>) for 8 days. Four days into this regimen, calcinosis was induced by subcutaneous injections of 500,000 IU/kg vitamin D at Oh, 24h and 48h. Ninety-six hours after the final vitamin D injection, the rats were killed and aortas and their hearts were removed for histological and calcium analyses. The data showed that phytate-treated rats had lower levels of aortic calcium than placebo-treated rats. All groups had similar heart calcium levels. Conclusions The present study found that phytate acted as a vascular calcification inhibitor. Thus, the action of polyphosphates could be important in protecting against vascular calcification.
社団法人日本循環器学会の論文
2007-06-20

Effect of Crystallization Inhibitors on Vascular Calcifications Induced by Vitamin D : A Pilot Study in Sprague-Dawley Rats

スポンサーリンク

概要

著者

関連論文

スポンサーリンク